Latest Regulatory News

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

JPMorgan Asset Management has announced the final cash distributions for February 2025 across several of its active ETFs, providing investors with key dates and reinvestment options.

Metrics Real Estate Multi-Strategy Fund has updated its dividend announcement, confirming an ordinary distribution of AUD 0.0096 per unit for the month ending January 31, 2025, payable on February 10.

Eureka Group Holdings has acquired a mixed-use residential park in Gladstone, marking its strategic entry into the all-age rental market with promising yield and expansion potential.

Garda Property Group reported a net loss of $10.19 million for the half-year ended December 31, 2024, yet maintained its interim dividend, signaling resilience amid asset value declines.

Carnaby Resources has completed the settlement of Tranche 2 of its recent share placement, issuing 13.5 million new shares to raise approximately $4.2 million, including participation from its board members.

Blackstone Minerals is set to merge with IDM International, combining expertise and local presence to advance exploration of the world-class Mankayan copper-gold porphyry project in the Philippines.

Arizona Lithium has unveiled a detailed, phased development plan for its Prairie Lithium Project, aiming to become North America’s first commercial lithium brine producer. The company targets initial production in 2025 with a modest capital outlay and scalable expansion strategy.

Blackstone Minerals has entered a binding scheme to acquire IDM International, securing the world-class Mankayan Copper-Gold Project in the Philippines. This merger positions Blackstone as a significant player in critical energy transition metals with promising exploration upside.

Infini Resources has successfully raised AUD$3.4 million through a flow-through share placement at a significant premium, positioning the company to aggressively advance exploration at its Portland Creek Uranium Project in Newfoundland.

WA Kaolin Limited has announced a fully underwritten pro-rata accelerated non-renounceable rights offer to raise approximately $7 million, aiming to bolster working capital and support production ramp-up at its Wickepin operations.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.